Axial Therapeuticsincis A Clinical Stage Biopharmaceutical Company Based In Massachusettsthe Company Specializes In Developing Gut Restricted Small Molecule Therapeutics Through Its Proprietary Microbial Inspired Therapeuticsaplatformaxial Focuses On The Gut Brain Axis And Its Impact On Central Nervous Systemcnsdisordersleveraging Over A Decade Of Research To Identify Microbiome Driven Drug Targets The Company Is Advancing Its Pipeline With Products Like Ab 2004A Phase 2 Therapeutic Aimed At Addressing Irritability And Core Symptoms Of Autismadditionallyaxial Has Initiated Phase 1 Clinical Trials For A Program Targeting Parkinsonae S Diseasewith Further Preclinical Initiatives In Liver Disease And Oncologyaxial Employs Advanced Preclinical Models To Study Microbiome Host Interactionsensuring That Its Therapeutics Act Locally In The Gastrointestinal Tract To Minimize Off Target Effects
